| Literature DB >> 31237944 |
Saurav Brahmachari1,2,3, Saebom Lee1,2, Sangjune Kim1,2, Changqing Yuan1,2,3, Senthilkumar S Karuppagounder1,2,3, Preston Ge1,2,3, Rosa Shi1,2,3, Esther J Kim1,2,3, Alex Liu1,2,3, Donghoon Kim1,2,4, Stephan Quintin1,2, Haisong Jiang1,2,3, Manoj Kumar1,2,3, Seung Pil Yun1,2,3, Tae-In Kam1,2,3, Xiaobo Mao1,2,3, Yunjong Lee1,2,3, Deborah A Swing5, Lino Tessarollo5, Han Seok Ko1,2,4, Valina L Dawson1,2,3,6,7, Ted M Dawson1,2,3,7,8.
Abstract
α-Synuclein misfolding and aggregation plays a major role in the pathogenesis of Parkinson's disease. Although loss of function mutations in the ubiquitin ligase, parkin, cause autosomal recessive Parkinson's disease, there is evidence that parkin is inactivated in sporadic Parkinson's disease. Whether parkin inactivation is a driver of neurodegeneration in sporadic Parkinson's disease or a mere spectator is unknown. Here we show that parkin in inactivated through c-Abelson kinase phosphorylation of parkin in three α-synuclein-induced models of neurodegeneration. This results in the accumulation of parkin interacting substrate protein (zinc finger protein 746) and aminoacyl tRNA synthetase complex interacting multifunctional protein 2 with increased parkin interacting substrate protein levels playing a critical role in α-synuclein-induced neurodegeneration, since knockout of parkin interacting substrate protein attenuates the degenerative process. Thus, accumulation of parkin interacting substrate protein links parkin inactivation and α-synuclein in a common pathogenic neurodegenerative pathway relevant to both sporadic and familial forms Parkinson's disease. Thus, suppression of parkin interacting substrate protein could be a potential therapeutic strategy to halt the progression of Parkinson's disease and related α-synucleinopathies.Entities:
Keywords: PARIS; Parkinson’s disease; parkin; zinc finger protein 746; α-synuclein
Mesh:
Substances:
Year: 2019 PMID: 31237944 PMCID: PMC6658849 DOI: 10.1093/brain/awz172
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501